Shanghai Orsin Medical Technology Co., Ltd. miaomiao8615@orsins.com 86-021-57450666

Shanghai Orsin Medical Technology Co., Ltd. Company Profile
products
Home > products > Vacuum Blood Test Tube > Streamline Cell-Free DNA CF DNA Vacuum Blood Test Tube

Streamline Cell-Free DNA CF DNA Vacuum Blood Test Tube

Product Details

Place of Origin: Shanghai, China

Brand Name: Orsin

Certification: ISO 13485

Model Number: Cell-Free DNA

Payment & Shipping Terms

Minimum Order Quantity: 1000

Price: Negotiation

Payment Terms: L/C, D/A, D/P, T/T, Western Union

Get Best Price
Product Details
Highlight:

DNA Vacuum Blood Test Tube

,

Streamline Vacuum Blood Test Tube

Product Description

Accurate Volume DHA Sterile And Safe Compatible With Equipment Customization

 

1. Product Description


 

Unlock the future of precision medicine with Orsin Medical Technology's cutting-edge Cell-Free DNA (cfDNA) Testing Solutions. Our advanced, non-invasive technology harnesses the power of circulating cfDNA to deliver highly accurate, real-time insights into genetic abnormalities, cancer detection, prenatal screening, and disease monitoring.

Why Choose Orsin’s cf DNA Technology?
Ultra-Sensitive Detection: Capture even the faintest genetic signals for early and reliable diagnosis.
Comprehensive Profiling: Analyze multiple biomarkers from a simple blood draw, reducing the need for invasive procedures.
Clinical Excellence: Backed by rigorous research and AI-driven bioinformatics for unmatched accuracy.
Personalized Care: Empower healthcare providers with actionable data to tailor treatment strategies.

From oncology to reproductive health, Orsin Medical Technology is pioneering the next generation of liquid biopsy – making diagnostics faster, safer, and more accessible

   

2. Specification


 

 

Attribute Feature
Technology Next-generation sequencing (NGS) & AI-powered bioinformatics for ultra-sensitive cfDNA analysis.
Applications Cancer detection, prenatal screening, transplant monitoring, infectious disease profiling.
Sample Type Non-invasive (peripheral blood draw); minimal sample volume required.
Turnaround Time Rapid results (3–7 days), optimized for clinical decision-making.
Accuracy >99% specificity; detects low-frequency mutations (0.1% variant allele frequency).
Coverage Pan-cancer panels, fetal aneuploidy screening, custom biomarker options.
Regulatory CE-marked/IVD-certified (adapt to your compliance status, e.g., FDA pending).
Integration Compatible with hospital LIS/EHR systems; cloud-based reporting portal.
Advantage Reduces need for invasive biopsies; enables dynamic disease monitoring.

Key Differentiators:

  • Multimodal Analysis: Combiles cfDNA methylation, fragmentation, and mutation profiling.

  • Scalable Solutions: Tailored for research labs, clinics, and high-throughput diagnostics.

Let me know if you'd like to emphasize specific fields (e.g., oncology sensitivity, cost-efficiency) or adjust the compliance details!

 

3 . Application


1. Hospital Routine Testing

  • Scenario: Blood tests for routine diagnostics (CBC, biochemistry, coagulation) in outpatient/inpatient settings.

  • Adaptability:

    • Accurate Volume Control (±5% tolerance) ensures consistent results and reduces retesting rates.

    • Multiple additives (EDTA, heparin, sodium citrate) tailored for diverse testing requirements.

    • Compatibility with automated analyzers (e.g., Roche, Siemens, Abbott) and seamless integration with hospital LIS/HIS systems.


2. Emergency & Critical Care

  • Scenario: Rapid analysis of blood gases, electrolytes, and cardiac markers (e.g., troponin) in urgent care.

  • Adaptability:

    • DHA (Dual Hemostasis Activator) Technology accelerates blood separation, reducing preprocessing time (<15 minutes).

    • Gray-top tubes (sodium fluoride/potassium oxalate) prevent glucose degradation for accurate emergency glucose testing.


3. Research & Laboratory Studies

  • Scenario: Genomics (DNA/RNA extraction), proteomics, and drug metabolism research.

  • Adaptability:

    • Sterile, non-pyrogenic design eliminates exogenous contamination, ideal for high-sensitivity assays (e.g., PCR, ELISA).

    • Customization options: additive-free tubes, low-adsorption tubes, or pre-filled specialty anticoagulants (e.g., CPDA-1).


4. Blood Banking & Transfusion Medicine

  • Scenario: Blood component separation (plasma, RBCs, platelets), blood typing, and cross-matching.

  • Adaptability:

    • Blue-top sodium citrate tubes (3.2% concentration) comply with international coagulation standards (CLSI H21-A5).

    • High-strength PET material ensures leak-proof integrity for safe cold-chain transport.


5. Pediatrics & Special Populations

  • Scenario: Low-volume collection for neonates or patients with fragile veins.

  • Adaptability:

    • Custom small-volume tubes (1-2ml) minimize blood draw, with color-coded caps (pink/yellow) for easy identification.

    • Smooth inner walls reduce hemolysis risk, compatible with fine needles (≤25G).


6. Epidemiology & Public Health

  • Scenario: Large-scale screening (e.g., HIV, hepatitis, metabolic syndrome).

  • Adaptability:

    • Batch-customized tubes with pre-printed barcodes/QR codes enable rapid sample tracking.

    • High-temperature-resistant glass tubes (optional) for processing infectious samples.


7. Telemedicine & POCT (Point-of-Care Testing)

  • Scenario: Community clinics, home healthcare, and remote area testing.

  • Adaptability:

    • Gel-separator tubes (orange cap) stabilize plasma/serum for up to 72 hours at 25°C.

    • Lightweight design compatible with portable centrifuges and POCT devices (e.g., i-STAT).

    •  

    •  

    •  

    •